Skip to content

Optimal neurophysiological parameters in neuromuscular electrical stimulation in the treatment of dysphagia in multiple sclerosis - a pilot study

Optimal neurophysiological parameters in neuromuscular electrical stimulation in the treatment of dysphagia in multiple sclerosis - a pilot study - NMES for dysphagia in MS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON47927
Enrollment
25
Registered
2018-07-03
Start date
2018-07-31
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dysphagia Swallowing disorders

Interventions

The patients receive neuromuscular electrical stimulation during a test setting.

Sponsors

Nieuw Unicum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: (1) at least 18 years of age (2) a confirmed diagnosis of MS (3) a diagnosis of dysphagia determined by FEES characterized by incomplete hyoid movement.

Exclusion criteria

Exclusion criteria: (1) individuals with other neurological disorders (2) individuals with obstruction in nasal passage (FEES will not be possible) (3) individuals with significant cognitive deficits who cannot follow instructions during FEES or are not able to provide feedback on sensing stimulation or pain in their head and neck and (4) individuals who are medically not stable enough to be able to participate in FEES (e.g. pneumonia or fever) (5) radiotherapy in head/neck area or oncology of head/neck area (6) in case of heart problems, metal implants in head/neck area, inflamed skin, implanted stimulators or electronic devices participation should be evaluated by a medical doctor.

Design outcomes

Primary

MeasureTime frame
A protocol to determine optimal electrode placement and neuromuscular electrical stimulation parameters for NMES for dysphagia in individual MS patients.

Secondary

MeasureTime frame
The variability in location and type of motor dysfunctions of hyoid muscles in patients with MS visualized with ultrasonography.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)